Healthcare manufacturer builds new site with HSBC UK support
A medical components manufacturer and supplier has secured a £3.5 million finance facility from HSBC UK to build two new extensions to its existing facility, creating multiple new job opportunities for the local economy.
Unisurge, which manufactures and supplies a range of medical products, including surgical instruments and operating theatre products, will use the additional space at its existing site on Farboud Innovation Park to increase its production capacity by up to 50%.
Due to be opened before the year-end, the new extensions will feature innovative IT systems to help streamline and optimise production flow, and a state-of-the-art training facility which will be made available to the NHS for training and education.
The expansion follows the 2016 acquisition of Pennine Healthcare and will support future business opportunities, as well as provide an efficient, compliant and technically-advanced operation to create Unisurge’s range of bespoke products for hospital procedures.
John Farboud, chairman of Unisurge, said: “Our investment in state-of-the-art facilities demonstrates our commitment to providing service excellence to our customers and partners. Thanks to the continued support from HSBC UK, our extended headquarters will allow us to meet the growing demand for custom procedure packs and theatre products.
“The expansion has also meant we are recruiting the very best local talent to ensure our customers receive exactly what is required for their procedures. We’re looking forward to being fully operational and are excited about the growth potential this investment will bring.”
Jason Smithers, area director for HSBC UK in Cambridge, Essex & Suffolk, added: “Led by Chris Teale, our relationship director for Cambridge, HSBC UK has supported Unisurge’s growth over the past 30 years and we are delighted it now has a fantastic facility that reflects its forward-thinking philosophy. Unisurge is renowned for putting product innovation and performance at the forefront of its operations and this funding means the company is in a strong position to continue its growth plans over the coming years.”
Unisurge’s range of bespoke single use products is designed to be cost effective and patient specific. Hospitals receive all of the necessary components for a procedure which is created to their specification, in a sterile pack and ready for immediate use, and with short lead times as the company operates its own sterilisation plant and distribution fleet.